S&CO Inc. decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 7.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 94,280 shares of the exchange traded fund’s stock after selling 7,947 shares during the period. S&CO Inc.’s holdings in SPDR S&P Biotech ETF were worth $12,042,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Financial Life Planners bought a new stake in SPDR S&P Biotech ETF in the first quarter valued at about $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in SPDR S&P Biotech ETF during the 4th quarter worth approximately $27,000. Intesa Sanpaolo Wealth Management bought a new position in SPDR S&P Biotech ETF during the 4th quarter worth approximately $30,000. SHP Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $31,000. Finally, Legacy Wealth Managment LLC ID acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $32,000.
SPDR S&P Biotech ETF Trading Up 1.5%
Shares of NYSEARCA XBI opened at $154.26 on Friday. The company has a market capitalization of $10.43 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a twelve month low of $84.39 and a twelve month high of $165.71. The business has a 50 day simple moving average of $142.45 and a 200-day simple moving average of $132.39.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
